VRTX Insider Trading (Vertex Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.70%

Insider Buying (Last 12 Months): $3,260,400.00

Insider Selling (Last 12 Months): $90,911,898.88

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

^$213.35

▲ +3.07 (1.46%)

As of 04/9/2021 01:00 AM ET

Days: 30 | 90 | 365

April 30th is approaching, are you prepared?

From True Market Insiders | Ad

A new president’s policies always influence key stocks.

Here’s where top billionaires are investing.

Vertex Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/5/2021	Bastiano Sanna	EVP	Sell	1,686	$214.14	$361,040.04	36,223
2/11/2021	Bastiano Sanna	EVP	Sell	1,686	$210.56	$355,004.16	39,081
2/11/2021	Paul M Silva	CAO	Sell	1,498	$210.57	$315,433.86	24,073
2/5/2021	Michael Parini	EVP	Sell	1,930	$215.00	$414,950.00	59,157
2/3/2021	Michael Parini	EVP	Sell	400	$216.56	$86,624.00	35,276
11/10/2020	Bruce I Sachs	Director	Buy	15,000	$217.36	$3,260,400.00	18,035
11/3/2020	Stuart A Arbuckle	EVP	Sell	1,553	$211.92	$329,111.76	36,732
10/5/2020	Sangeeta N Bhatia	Director	Sell	10,516	$266.79	$2,805,563.64	14,424
8/3/2020	Amit Sachdev	EVP	Sell	1,941	$278.28	$540,141.48	37,044
7/13/2020	Michael Parini	EVP	Sell	2,125	$292.05	$620,606.25	28,963
7/13/2020	Paul M Silva	SVP	Sell	860	$292.03	$251,145.80	15,792
7/10/2020	Charles F Wagner Jr	CFO	Sell	700	$293.15	$205,205.00	16,786
7/7/2020	Stuart A Arbuckle	EVP	Sell	2,786	$300.00	$835,800.00	36,743
6/30/2020	Jeffrey M Leiden	Chairman	Sell	32,792	$286.15	$9,383,430.80	29,252
5/12/2020	Jeffrey M Leiden	Chairman	Sell	94,370	$283.47	$26,751,063.90	65,036
5/11/2020	Amit Sachdev	EVP	Sell	10,665	$282.61	$3,014,035.65	45,768
5/7/2020	Bruce I Sachs	Director	Sell	45,000	$269.80	$12,141,000.00	33,710
5/6/2020	Paul M Silva	SVP	Sell	1,076	$272.74	$293,468.24	15,397
5/5/2020	Amit Sachdev	EVP	Sell	13,356	$270.01	$3,606,253.56	67,603
5/5/2020	Jeffrey M Leiden	Chairman	Sell	94,372	$269.94	$25,474,777.68	76,707
5/4/2020	Paul M Silva	SVP	Sell	809	$260.87	$211,043.83	15,741
4/29/2020	Michael Parini	EVP	Sell	2,125	$254.95	$541,768.75	28,963
4/27/2020	Yuchun Lee	Director	Sell	2,000	$271.21	$542,420.00	3,875
4/24/2020	Yuchun Lee	Director	Sell	2,000	$268.14	$536,280.00	3,875
4/22/2020	Yuchun Lee	Director	Sell	2,000	$267.88	$535,760.00	3,875
4/20/2020	Yuchun Lee	Director	Sell	2,000	$273.16	$546,320.00	3,875
4/13/2020	Paul M Silva	SVP	Sell	859	$248.72	$213,650.48	15,791
4/6/2020	Paul M Silva	SVP	Sell	4,891	$255.57	$1,249,992.87	19,823
2/25/2020	Amit Sachdev	EVP	Sell	3,376	$233.53	$788,397.28	36,291
2/25/2020	Jeffrey M Leiden	CEO	Sell	10,550	$233.46	$2,463,003.00	103,131
2/25/2020	Ourania Tatsis	SVP	Sell	1,296	$233.17	$302,188.32	14,034
2/25/2020	Reshma Kewalramani	CMO	Sell	3,634	$233.45	$848,357.30	30,260
2/18/2020	Amit Sachdev	EVP	Sell	3,489	$243.56	$849,780.84	42,936
2/18/2020	Jeffrey M Leiden	CEO	Sell	11,685	$243.52	$2,845,531.20	123,226
2/18/2020	Ourania Tatsis	SVP	Sell	1,279	$243.62	$311,589.98	16,349
2/18/2020	Reshma Kewalramani	CMO	Sell	1,183	$243.51	$288,072.33	34,341
2/7/2020	Yuchun Lee	Director	Sell	2,000	$237.82	$475,640.00	3,875
2/4/2020	Yuchun Lee	Director	Sell	2,000	$238.84	$477,680.00	3,875
1/22/2020	Michael Parini	EVP	Sell	1	$237.50	$237.50	35,004
1/16/2020	Amit Sachdev	EVP	Sell	5,000	$235.00	$1,175,000.00	41,190
1/13/2020	Michael Parini	EVP	Sell	2,125	$226.78	$481,907.50	37,128
1/13/2020	Paul M Silva	SVP	Sell	860	$229.38	$197,266.80	18,619
1/8/2020	Amit Sachdev	EVP	Sell	5,000	$230.00	$1,150,000.00	41,190
1/8/2020	Paul M Silva	SVP	Sell	13,750	$231.89	$3,188,487.50	31,509
1/6/2020	Michael Parini	EVP	Sell	4,250	$222.00	$943,500.00	39,253
1/2/2020	Paul M Silva	SVP	Sell	25,630	$218.92	$5,610,919.60	34,517
1/2/2020	William D Young	Director	Sell	20,000	$218.93	$4,378,600.00	29,311
12/9/2019	Amit Sachdev	EVP	Sell	5,000	$225.00	$1,125,000.00	38,416
11/25/2019	Amit Sachdev	EVP	Sell	5,000	$220.00	$1,100,000.00	38,416
11/25/2019	Reshma Kewalramani	CMO	Sell	4,692	$219.37	$1,029,284.04	17,790
11/19/2019	Amit Sachdev	EVP	Sell	5,000	$215.00	$1,075,000.00	38,416
11/18/2019	Jeffrey M Leiden	CEO	Sell	9,434	$216.75	$2,044,819.50	170,378
11/13/2019	Michael Parini	EVP	Sell	4,892	$205.50	$1,005,306.00	39,895
11/13/2019	Ourania Tatsis	SVP	Sell	2,853	$205.59	$586,548.27	10,105
11/8/2019	Reshma Kewalramani	CMO	Sell	509	$199.00	$101,291.00	13,607
11/6/2019	David Altshuler	EVP	Sell	1,223	$197.21	$241,187.83	32,776
11/4/2019	Amit Sachdev	EVP	Sell	4,097	$200.34	$820,792.98	35,571
11/1/2019	Jeffrey M Leiden	CEO	Sell	96,822	$200.02	$19,366,336.44	115,166
11/1/2019	Sangeeta N Bhatia	Director	Sell	1,291	$200.00	$258,200.00	6,540
10/30/2019	Reshma Kewalramani	CMO	Sell	3,057	$199.00	$608,343.00	16,155
10/25/2019	Amit Sachdev	EVP	Sell	4,311	$197.89	$853,103.79	37,727
10/22/2019	Amit Sachdev	EVP	Sell	3,883	$190.27	$738,818.41	37,299
10/22/2019	Jeffrey M Leiden	CEO	Sell	107,831	$190.00	$20,487,890.00	178,707
10/22/2019	Margaret G Mcglynn	Director	Sell	20,000	$190.00	$3,800,000.00	24,124
10/22/2019	Reshma Kewalramani	CMO	Sell	638	$189.00	$120,582.00	13,098
10/17/2019	Michael Parini	EVP	Sell	4,250	$177.80	$755,650.00	39,253
10/14/2019	Michael Parini	EVP	Sell	2,125	$174.06	$369,877.50	37,128
10/2/2019	Sangeeta N Bhatia	Director	Sell	8,379	$166.80	$1,397,617.20	7,810
10/1/2019	Ourania Tatsis	SVP	Sell	188	$169.11	$31,792.68	7,696
8/19/2019	David Altshuler	EVP	Sell	12,501	$186.38	$2,329,936.38	35,803
8/13/2019	Margaret G Mcglynn	Director	Sell	10,000	$185.00	$1,850,000.00	14,124
8/8/2019	Stuart A Arbuckle	EVP	Sell	2,125	$181.89	$386,516.25	35,365
8/5/2019	Michael Parini	EVP	Sell	2,330	$175.28	$408,402.40	34,395
8/2/2019	Stuart A Arbuckle	EVP	Sell	2,155	$177.78	$383,115.90	34,395
7/12/2019	Michael Parini	EVP	Sell	2,125	$175.27	$372,448.75	37,128
7/5/2019	Michael Parini	EVP	Sell	4,250	$179.11	$761,217.50	39,253
6/19/2019	Stuart A Arbuckle	EVP	Sell	2,125	$181.89	$386,516.25	35,365
6/18/2019	Jeffrey M Leiden	CEO	Sell	56,030	$175.39	$9,827,101.70	162,317
6/3/2019	Sangeeta N Bhatia	Director	Sell	720	$167.08	$120,297.60	7,260
5/24/2019	Jeffrey M Leiden	CEO	Sell	113,432	$175.10	$19,861,943.20	219,719
5/15/2019	Amit Sachdev	EVP	Sell	61	$165.41	$10,090.01	33,416
5/15/2019	Paul M Silva	SVP	Sell	161	$165.41	$26,631.01	17,759
5/15/2019	Reshma Kewalramani	CMO	Sell	241	$165.41	$39,863.81	13,736
5/6/2019	Jeffrey M Leiden	CEO	Sell	33,058	$175.01	$5,785,480.58	136,953
5/3/2019	Michael Parini	EVP	Sell	1,622	$172.06	$279,081.32	37,332
5/1/2019	Jeffrey M Leiden	CEO	Sell	10,480	$175.08	$1,834,838.40
4/15/2019	Stuart A Arbuckle	EVP	Sell	5,624	$181.75	$1,022,162.00	36,272
2/19/2019	David Altshuler	EVP	Sell	5,624	$187.00	$1,051,688.00	32,604
2/19/2019	Jeffrey M Leiden	CEO	Sell	20,997	$186.98	$3,926,019.06	110,095
2/19/2019	Paul M Silva	SVP	Sell	2,812	$186.97	$525,759.64	18,903
2/19/2019	Reshma Kewalramani	CMO	Sell	1,488	$186.94	$278,166.72	14,038
2/11/2019	Jeffrey M Leiden	CEO	Sell	111,431	$180.24	$20,084,323.44	223,916
2/11/2019	Michael Parini	EVP	Sell	12,136	$180.22	$2,187,149.92	60,050
2/11/2019	Paul M Silva	SVP	Sell	4,215	$180.16	$759,374.40	23,386
2/6/2019	Paul M Silva	SVP	Sell	1,289	$193.00	$248,777.00	13,938
2/4/2019	Jeffrey M Leiden	CEO	Sell	32,250	$186.35	$6,009,787.50	155,815
2/4/2019	Michael Parini	EVP	Sell	2,330	$189.19	$440,812.70	38,489
2/4/2019	Paul M Silva	SVP	Sell	4,247	$187.02	$794,273.94	16,896
2/1/2019	Michael Parini	EVP	Sell	3,450	$190.92	$658,674.00
1/22/2019	David Altshuler	EVP	Sell	2,125	$193.48	$411,145.00	41,238
1/18/2019	David Altshuler	EVP	Sell	1,223	$194.62	$238,020.26	40,336
1/17/2019	Paul M Silva	SVP	Sell	3,007	$190.62	$573,194.34	17,376
1/14/2019	Michael Parini	EVP	Sell	2,125	$186.71	$396,758.75	41,734
1/4/2019	Michael Parini	EVP	Sell	4,250	$165.90	$705,075.00	43,859
12/3/2018	Paul M Silva	SVP	Sell	809	$186.52	$150,894.68	16,896
11/15/2018	David Altshuler	EVP	Sell	100	$163.75	$16,375.00
11/15/2018	Paul M Silva	SVP	Sell	12	$163.75	$1,965.00	16,087
11/7/2018	David Altshuler	EVP	Sell	2,125	$181.89	$386,516.25	48,877
11/5/2018	David Altshuler	EVP	Sell	4,126	$173.51	$715,902.26	40,909
11/2/2018	Stuart A Arbuckle	EVP	Sell	2,155	$175.36	$377,900.80	48,907
10/12/2018	Michael Parini	EVP	Sell	2,125	$177.20	$376,550.00	41,734
10/8/2018	Reshma Kewalramani	CMO	Sell	2,305	$186.95	$430,919.75	1,909
10/4/2018	Michael Parini	EVP	Sell	4,250	$191.58	$814,215.00	43,859
10/3/2018	Sangeeta N Bhatia	Director	Sell	6,818	$192.13	$1,309,942.34	6,997
10/1/2018	David Altshuler	EVP	Sell	2,445	$194.62	$475,845.90
10/1/2018	Thomas Graney	CFO	Sell	1,076	$193.24	$207,926.24
8/28/2018	David Altshuler	EVP	Sell	2,125	$181.89	$386,516.25	41,238
8/3/2018	Paul M Silva	SVP	Sell	2,098	$174.44	$365,975.12	17,376
8/3/2018	Stuart A Arbuckle	EVP	Sell	10,083	$175.29	$1,767,449.07	48,877
7/16/2018	Paul M Silva	SVP	Sell	860	$179.85	$154,671.00	16,947
7/16/2018	Stuart A Arbuckle	EVP	Sell	8,500	$179.21	$1,523,285.00	53,127
7/12/2018	Michael Parini	EVP	Sell	2,125	$175.02	$371,917.50	41,734
7/12/2018	Paul M Silva	SVP	Sell	860	$175.02	$150,517.20	16,947
7/5/2018	Michael Parini	EVP	Sell	4,250	$168.38	$715,615.00	43,859
6/29/2018	Amit Sachdev	EVP	Sell	4,096	$167.63	$686,612.48	48,603
6/29/2018	Ian F Smith	COO	Sell	23,375	$166.30	$3,887,262.50	70,074
6/29/2018	Paul M Silva	SVP	Sell	2,957	$166.52	$492,399.64	16,946
6/22/2018	Ian F Smith	COO	Sell	4,250	$160.00	$680,000.00	50,949
6/22/2018	Jeffrey M Leiden	CEO	Sell	140,211	$160.00	$22,433,760.00	297,260
6/4/2018	Sangeeta N Bhatia	Director	Sell	875	$152.05	$133,043.75	5,754
5/15/2018	Ian F Smith	COO	Sell	217	$155.78	$33,804.26	46,699
5/15/2018	Paul M Silva	SVP	Sell	201	$155.78	$31,311.78	16,087
5/15/2018	Stuart A Arbuckle	EVP	Sell	138	$155.78	$21,497.64	46,662
5/11/2018	Ian F Smith	COO	Sell	4,096	$155.00	$634,880.00
5/3/2018	Michael Parini	EVP	Sell	2,330	$149.50	$348,335.00	41,939
4/26/2018	Ian F Smith	COO	Sell	85,093	$158.32	$13,471,923.76	68,745
4/26/2018	Michael Parini	EVP	Sell	40,764	$159.29	$6,493,297.56	42,123
4/18/2018	Paul M Silva	SVP	Sell	859	$166.05	$142,636.95	16,946
4/16/2018	Stuart A Arbuckle	EVP	Sell	2,125	$163.01	$346,396.25	48,877

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

92.17% of Vertex Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/9/2021	EFG Asset Management Americas Corp.	1,582	$0.34M	0.1%	+22.9%	0.001%
4/9/2021	Ipswich Investment Management Co. Inc.	6,320	$1.36M	0.4%	N/A	0.002%
4/9/2021	State of Alaska Department of Revenue	40,729	$8.75M	0.1%	-4.3%	0.016%
4/9/2021	Selective Wealth Management Inc.	150	$32K	0.0%	+50.0%	0.000%
4/9/2021	NuWave Investment Management LLC	1,352	$0.29M	0.4%	N/A	0.001%
4/6/2021	UMA Financial Services Inc.	967	$0.21M	0.1%	N/A	0.000%
4/6/2021	Chesley Taft & Associates LLC	3,814	$0.82M	0.0%	-54.5%	0.001%
4/6/2021	Carroll Financial Associates Inc.	414	$88K	0.0%	+13.1%	0.000%
4/6/2021	LVM Capital Management Ltd. MI	29,185	$6.27M	1.0%	+1.4%	0.011%
4/6/2021	Everence Capital Management Inc.	5,704	$1.23M	0.1%	N/A	0.002%
4/5/2021	Pacer Advisors Inc.	24,123	$5.18M	0.1%	-8.1%	0.009%
4/5/2021	Woodstock Corp	4,289	$0.92M	0.1%	-14.5%	0.002%
3/31/2021	SWS Partners	3,785	$0.90M	0.4%	+37.4%	0.001%
3/30/2021	Koshinski Asset Management Inc.	2,428	$0.57M	0.1%	+16.3%	0.001%
3/24/2021	Alpha DNA Investment Management LLC	271	$64K	0.1%	N/A	0.000%
3/12/2021	DekaBank Deutsche Girozentrale	234,495	$54.69M	0.2%	-8.2%	0.090%
3/9/2021	Defined Wealth Management LLC	880	$0.21M	0.2%	N/A	0.000%
3/9/2021	Childress Capital Advisors LLC	315	$74K	0.0%	N/A	0.000%
3/9/2021	Amundi Pioneer Asset Management Inc.	817,089	$193.11M	0.2%	+87.9%	0.314%
3/9/2021	Tealwood Asset Management Inc.	6,035	$1.43M	0.7%	+69.1%	0.002%
3/8/2021	B. Metzler seel. Sohn & Co. Holding AG	16,789	$3.92M	0.1%	N/A	0.006%
3/8/2021	Teachers Retirement System of The State of Kentucky	129,010	$30.49M	0.3%	-5.6%	0.050%
3/8/2021	Harvest Volatility Management LLC	3,486	$0.82M	0.1%	N/A	0.001%
3/8/2021	Dimensional Fund Advisors LP	454,549	$107.42M	0.0%	+4.4%	0.175%
3/5/2021	Voya Financial Advisors Inc.	903	$0.21M	0.0%	-18.1%	0.000%
3/4/2021	Hudson Bay Capital Management LP	30,000	$7.09M	0.1%	+200.0%	0.012%
3/4/2021	Moody National Bank Trust Division	29,766	$7.04M	0.2%	+0.4%	0.011%
3/2/2021	SkyView Investment Advisors LLC	1,303	$0.31M	0.1%	N/A	0.001%
3/2/2021	Norges Bank	2,771,326	$654.98M	0.2%	N/A	1.066%
3/2/2021	Capital Asset Advisory Services LLC	456	$0.11M	0.0%	N/A	0.000%
3/2/2021	Livforsakringsbolaget Skandia Omsesidigt	14,287	$3.38M	0.3%	+26.6%	0.005%
3/1/2021	UBS Asset Management Americas Inc.	2,087,167	$493.28M	0.2%	+29.3%	0.803%
3/1/2021	Healthcare of Ontario Pension Plan Trust Fund	85,198	$20.14M	0.1%	+258,075.8%	0.033%
3/1/2021	Main Street Financial Solutions LLC	1,514	$0.36M	0.1%	N/A	0.001%
2/26/2021	Avitas Wealth Management LLC	5,076	$1.20M	0.2%	+24.2%	0.002%
2/26/2021	Doheny Asset Management CA	1,375	$0.33M	0.2%	N/A	0.001%
2/25/2021	Dimensional Fund Advisors LP	454,549	$107.42M	0.0%	+4.4%	0.175%
2/24/2021	Broadleaf Partners LLC	30,885	$7.30M	2.9%	+0.2%	0.012%
2/24/2021	Bank Julius Baer & Co. Ltd Zurich	16,248	$3.84M	0.0%	+93.5%	0.006%
2/23/2021	Principal Financial Group Inc.	348,629	$82.40M	0.1%	-5.1%	0.134%
2/19/2021	JPMorgan Chase & Co.	2,588,024	$611.65M	0.1%	+15.5%	0.996%
2/19/2021	AtonRa Partners	11,560	$2.73M	1.3%	N/A	0.004%
2/19/2021	Berman Capital Advisors LLC	354	$83K	0.0%	-17.3%	0.000%
2/19/2021	International Biotechnology Trust PLC	97,322	$22.98M	6.3%	+50.1%	0.037%
2/19/2021	Rehmann Capital Advisory Group	1,824	$0.43M	0.0%	-10.1%	0.001%
2/19/2021	National Pension Service	354,093	$83.69M	0.2%	+6.6%	0.136%
2/18/2021	Verition Fund Management LLC	884	$0.21M	0.0%	-23.3%	0.000%
2/18/2021	Strategic Wealth Partners Ltd.	1,027	$0.24M	0.1%	N/A	0.000%
2/18/2021	Symmetry Partners LLC	1,877	$0.44M	0.0%	-4.0%	0.001%
2/18/2021	Truist Financial Corp	39,521	$9.34M	0.0%	-6.4%	0.015%
2/17/2021	Voloridge Investment Management LLC	260,785	$61.63M	0.5%	+297.5%	0.100%
2/17/2021	IHT Wealth Management LLC	5,072	$1.20M	0.1%	+91.9%	0.002%
2/17/2021	Castleark Management LLC	730	$0.17M	0.0%	-21.5%	0.000%
2/17/2021	United Capital Financial Advisers LLC	3,035	$0.72M	0.0%	-87.5%	0.001%
2/17/2021	Cim Investment Mangement Inc.	1,772	$0.42M	0.1%	N/A	0.001%
2/17/2021	Baker Avenue Asset Management LP	2,238	$0.53M	0.0%	-61.2%	0.001%
2/17/2021	Canada Pension Plan Investment Board	53,298	$12.60M	0.0%	-23.0%	0.020%
2/17/2021	Advisor Partners LLC	6,878	$1.63M	0.1%	-9.6%	0.003%
2/17/2021	Prestige Wealth Management Group LLC	148	$35K	0.0%	-27.8%	0.000%
2/17/2021	Cetera Investment Advisers	17,201	$4.07M	0.1%	+241.0%	0.007%
2/17/2021	Cetera Advisors LLC	4,843	$1.15M	0.0%	+15.3%	0.002%
2/17/2021	Kiwi Wealth Investments Limited Partnership	23,460	$5.55M	0.3%	+849.0%	0.009%
2/16/2021	Orbimed Advisors LLC	834,100	$197.13M	1.7%	+25.2%	0.321%
2/16/2021	Zacks Investment Management	28,747	$6.79M	0.1%	-22.6%	0.011%
2/16/2021	Tokio Marine Asset Management Co. Ltd.	1,747	$0.41M	0.0%	+10.2%	0.001%
2/16/2021	Silverarc Capital Management LLC	5,000	$1.18M	0.7%	N/A	0.002%
2/16/2021	Squarepoint Ops LLC	6,840	$1.62M	0.0%	-89.5%	0.003%
2/16/2021	Mcdonald Partners LLC	1,673	$0.40M	0.1%	N/A	0.001%
2/16/2021	Headinvest LLC	1,033	$0.24M	0.0%	N/A	0.000%
2/16/2021	Glenmede Trust Co. NA	65,617	$15.51M	0.1%	+1,693.3%	0.025%
2/16/2021	Morgan Stanley	917,848	$216.92M	0.0%	+18.7%	0.353%
2/16/2021	Cozad Asset Management Inc.	3,930	$0.93M	0.2%	+12.0%	0.002%
2/16/2021	Principal Street Partners LLC	4,434	$1.05M	0.3%	+5.4%	0.002%
2/16/2021	Toroso Investments LLC	2,055	$0.49M	0.0%	+41.9%	0.001%
2/16/2021	Paloma Partners Management Co	12,030	$2.84M	0.1%	+447.6%	0.005%
2/16/2021	LMR Partners LLP	15,989	$3.78M	0.1%	+529.0%	0.006%
2/16/2021	Tudor Investment Corp Et Al	46,303	$10.94M	0.3%	+711.9%	0.018%
2/16/2021	Knights of Columbus Asset Advisors LLC	11,651	$2.75M	0.3%	-22.0%	0.004%
2/16/2021	Nuveen Asset Management LLC	2,637,754	$623.41M	0.2%	-24.7%	1.014%
2/16/2021	Davidson Kempner Capital Management LP	44,600	$10.53M	0.2%	N/A	0.017%
2/16/2021	Captrust Financial Advisors	1,673	$0.40M	0.0%	-63.7%	0.001%
2/16/2021	Colony Group LLC	1,421	$0.34M	0.0%	-40.9%	0.001%
2/16/2021	Guggenheim Capital LLC	209,790	$49.58M	0.3%	+9.2%	0.081%
2/16/2021	Price T Rowe Associates Inc. MD	19,626,924	$4.63B	0.5%	-3.7%	7.548%
2/16/2021	Kingsview Wealth Management LLC	3,715	$0.88M	0.1%	+52.6%	0.001%
2/16/2021	Amundi Pioneer Asset Management Inc.	817,089	$193.11M	0.2%	+87.9%	0.314%
2/16/2021	Alpha DNA Investment Management LLC	249	$58K	0.1%	N/A	0.000%
2/16/2021	Virginia Retirement Systems ET AL	119,200	$28.17M	0.3%	+66.0%	0.046%
2/16/2021	New York Life Investments Alternatives	1,792	$0.42M	0.3%	N/A	0.001%
2/16/2021	ETF Managers Group LLC	1,164	$0.27M	0.0%	-55.6%	0.000%
2/16/2021	Schroder Investment Management Group	25,559	$6.04M	0.0%	-5.5%	0.010%
2/16/2021	Engineers Gate Manager LP	2,579	$0.61M	0.0%	-78.2%	0.001%
2/16/2021	Ashford Capital Management Inc.	5,709	$1.35M	0.1%	+4.0%	0.002%
2/16/2021	Avidity Partners Management LP	147,300	$34.81M	1.1%	N/A	0.057%
2/16/2021	Janus Henderson Group PLC	4,166,534	$984.70M	0.5%	+119.2%	1.602%
2/16/2021	A.R.T. Advisors LLC	2,824	$0.67M	3.1%	N/A	0.001%
2/16/2021	ExodusPoint Capital Management LP	18,913	$4.47M	0.0%	+177.2%	0.007%
2/16/2021	Benjamin F. Edwards & Company Inc.	3,400	$0.80M	0.0%	+3.6%	0.001%
2/16/2021	Capital International Ltd.	81,159	$19.18M	1.1%	-1.3%	0.031%
2/16/2021	Parametrica Management Ltd	923	$0.22M	0.1%	N/A	0.000%

Data available starting January 2016

Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 12 years of age or older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator, or CFTR, gene. Its pipeline includes Pipeline for Alpha-1 antitrypsin deficiency that is in Phase 2 clinical trial; VX-864, a second investigational small molecule corrector for the treatment of AAT deficiency, which is in Phase 1 clinical trial; and VX-147 that completed a Phase 1 clinical trial for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. Vertex Pharmaceuticals Incorporated has collaborations with CRISPR Therapeutics AG; Arbor Biotechnologies, Inc.; Moderna, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany; X-Chem, Inc.; Janssen Pharmaceuticals, Inc.; Merck KGaA; Kymera Therapeutics; Ribometrix, Inc.; Molecular Templates, Inc.; and Affinia Therapeutics. The company was founded in 1989 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $213.35

$209.53

$213.82

50 Day Range

MA: $213.45

$207.02

$219.65

52 Week Range

Now: $213.35

$202.57

$306.08

Volume

1,519,333 shs

Average Volume

2,072,177 shs

Market Capitalization

$55.46 billion

P/E Ratio

26.94

Dividend Yield

N/A

Beta

0.79

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?

Vertex Pharmaceuticals' top insider shareholders include:

Jeffrey M Leiden (CEO)
Jeffrey M Leiden (Chairman)
Amit Sachdev (EVP)
Michael Parini (EVP)
Bastiano Sanna (EVP)
Stuart A Arbuckle (EVP)
David Altshuler (EVP)
Paul M Silva (SVP)
Reshma Kewalramani (CMO)
Bruce I Sachs (Director)
William D Young (Director)
Margaret G Mcglynn (Director)
Paul M Silva (CAO)
Charles F Wagner Jr (CFO)
Ourania Tatsis (SVP)
Sangeeta N Bhatia (Director)
Yuchun Lee (Director)

Who are the major institutional investors of Vertex Pharmaceuticals?

Vertex Pharmaceuticals' top institutional investors include:

State of Alaska Department of Revenue — 0.02%
LVM Capital Management Ltd. MI — 0.01%
Pacer Advisors Inc. — 0.01%
Ipswich Investment Management Co. Inc. — 0.00%
Everence Capital Management Inc. — 0.00%
Woodstock Corp — 0.00%

Which major investors are selling Vertex Pharmaceuticals stock?

Within the previous quarter, VRTX stock was sold by these institutional investors:

Chesley Taft & Associates LLC
Pacer Advisors Inc.
State of Alaska Department of Revenue
Woodstock Corp

In the last year, company insiders that have sold Vertex Pharmaceuticals company stock include:

Jeffrey M Leiden (CEO)
Jeffrey M Leiden (Chairman)
Amit Sachdev (EVP)
Michael Parini (EVP)
Bastiano Sanna (EVP)
Stuart A Arbuckle (EVP)
David Altshuler (EVP)
Paul M Silva (SVP)
Reshma Kewalramani (CMO)
Bruce I Sachs (Director)
William D Young (Director)

Which major investors are buying Vertex Pharmaceuticals stock?

During the previous quarter, VRTX stock was acquired by institutional investors including:

Ipswich Investment Management Co. Inc.
Everence Capital Management Inc.
NuWave Investment Management LLC
UMA Financial Services Inc.
LVM Capital Management Ltd. MI
EFG Asset Management Americas Corp.
Selective Wealth Management Inc.
Carroll Financial Associates Inc.